Emmanuel L. Bravo
Keynote Forum: J Nephrol Therapeut
S ince the original description of Primary Aldosteronism in 1954 by Dr. Jerome Conn, several studies have emerged that have added to our understanding of the pathogenesis of the disease, its clinical manifestations, and the diagnostic criteria that we now employ to arrive at a definitive diagnosis. This presentation will review the various pathways that aldosterone can produce hypertension, the cardiovascular complications that result from excessive aldosterone production, and the various tools that one can use to arrive at a definitive diagnosis of Primary Aldosteronism.
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report